IE
AVIR icon

Israel Englander’s Atea Pharmaceuticals AVIR Stock Holding History

Israel Englander’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
304,611
-45,321
-13% -$225K ﹤0.01% 4094
2026
Q1 		$1.88M Sell
349,932
-348,224
-50% -$1.6M ﹤0.01% 3922
2025
Q4 		$2.49M Buy
698,156
+210,933
+43% +$670K ﹤0.01% 3745
2025
Q3 		$1.41M Buy
487,223
+312,733
+179% +$1.07M ﹤0.01% 4349
2025
Q2 		$628K Buy
174,490
+97,928
+128% +$292K ﹤0.01% 4740
2025
Q1 		$229K Buy
76,562
+54,056
+240% +$169K ﹤0.01% 5240
2024
Q4 		$75.4K Buy
+22,506
New +$74.8K ﹤0.01% 5527
2024
Q2 		– Sell
-212,763
Closed -$860K – 5869
2024
Q1 		$860K Buy
212,763
+197,163
+1,264% +$772K ﹤0.01% 4428
2023
Q4 		$47.6K Sell
15,600
-27,784
-64% -$84.1K ﹤0.01% 5483
2023
Q3 		$130K Sell
43,384
-24,406
-36% -$83K ﹤0.01% 5266
2023
Q2 		$254K Sell
67,790
-4,868
-7% -$18.2K ﹤0.01% 4998
2023
Q1 		$243K Sell
72,658
-107,028
-60% -$434K ﹤0.01% 5055
2022
Q4 		$864K Buy
+179,686
New +$909K ﹤0.01% 4304
2021
Q4 		– Sell
-115,671
Closed -$4.05M – 6769
2021
Q3 		$4.05M Buy
+115,671
New +$3.21M ﹤0.01% 3117
2021
Q2 		– Sell
-32,420
Closed -$2M – 6510
2021
Q1 		$2M Buy
+32,420
New +$2.19M ﹤0.01% 3533

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Israel Englander's AVIR Position: Q2 2026 in Review

Israel Englander reduced its Atea Pharmaceuticals (AVIR) stake by 13% in Q2 2026, selling an estimated $225K and leaving 304,611 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4094.

Israel Englander first reported a position in AVIR in Q1 2021 and has held it in 15 quarters since. The position peaked at $4.05M in Q3 2021. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Israel Englander held 304,611 shares of Atea Pharmaceuticals worth $1.42M as of Q2 2026.
  • Israel Englander sold 45,321 Atea Pharmaceuticals shares in Q2 2026, an estimated $225K.
  • Atea Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4094 holding.
  • Israel Englander first reported a position in Atea Pharmaceuticals in Q1 2021 and has held it in 15 quarters since.
  • Israel Englander's Atea Pharmaceuticals position peaked at $4.05M in Q3 2021.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.